MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20244224

June 28, 2024

Drug Information

玻璃酸钠滴眼液

眼用制剂

0.1%(0.4ml:0.4mg)

化学药品

June 28, 2024

Company Information

Applicant Company

太仓港港口开发区石化区协鑫西路12号

Manufacturing Company

江苏太仓港港口开发区石化区协鑫西路12号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠滴眼液 - NMPA 批准文号 | MedPath